Brooks Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 25.73 | 23.94 | 20.54 |
| Operating Expense | 22.39 | 21.74 | 18.94 |
| Net Profit | 2.65 | 1.37 | 0.94 |
| Net Profit Margin | 10.30 | 5.72 | 4.58 |
| Earning Per Share | 0.90 | 0.51 | 0.28 |
| EBIDTA | 3.34 | 2.20 | 1.60 |
| Effective Tax Rate | TBA | 8.18 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 25.73 |
| Operating Expense | 22.39 |
| Net Profit | 2.65 |
| Net Profit Margin | 10.30 |
| Earning Per Share | 0.90 |
| EBIDTA | 3.34 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 82.56 | 79.49 | 55.54 |
| Operating Expenses Annual | 77.58 | 76.23 | 61.35 |
| Operating Profit Annual | 5.86 | 4.17 | -5.70 |
| Interest Annual | 1.03 | 0.84 | 0.77 |
| Depreciation | 1.60 | 1.77 | 1.72 |
| Net Profit Annual | 3.05 | 1.53 | -8.18 |
| Tax Annual | 0.18 | 0.03 | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 82.56 |
| Operating Expenses Annual | 77.58 |
| Operating Profit Annual | 5.86 |
| Interest Annual | 1.03 |
| Depreciation | 1.60 |
| Net Profit Annual | 3.05 |
| Tax Annual | 0.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.13 | 0.02 | 0.08 |
| Cash Flow from Operations | 2.63 | -9.80 | 0.55 |
| Cash Flow from Investing | -45.14 | 0.18 | -0.40 |
| Cash Flow from Financing | 42.43 | 9.72 | -0.21 |
| Cash Flow at the End | 0.04 | 0.13 | 0.02 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.13 |
| Cash Flow from Operations | 2.63 |
| Cash Flow from Investing | -45.14 |
| Cash Flow from Financing | 42.43 |
| Cash Flow at the End | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 7.10 | 5.25 | -10.26 |
| PBIT Margin (%) | 5.16 | 3.02 | -13.36 |
| PBT Margin (%) | 0.15 | -0.58 | 3.96 |
| Net PROFIT Margin (%) | 3.69 | 1.92 | -14.73 |
| Return On Networth / Equity (%) | 2.43 | 1.90 | TBA |
| Return On Networth /Employed (%) | 3.19 | 2.72 | TBA |
| Return On Assets (%) | 3.03 | 2.16 | -11.78 |
| Total Debt / Equity (X) | 0.07 | 0.10 | 0.10 |
| Asset Turnover Ratio (%) | 0.82 | 1.12 | 0.80 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 7.10 |
| PBIT Margin (%) | 5.16 |
| PBT Margin (%) | 0.15 |
| Net PROFIT Margin (%) | 3.69 |
| Return On Networth / Equity (%) | 2.43 |
| Return On Networth /Employed (%) | 3.19 |
| Return On Assets (%) | 3.03 |
| Total Debt / Equity (X) | 0.07 |
| Asset Turnover Ratio (%) | 0.82 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 13.98 | 13.67 | 15.01 |
| Total Current Assets Annual | 33.88 | 31.05 | 27.61 |
| Non Current Assets Annual | 106.78 | 63.34 | 64.82 |
| Total Shareholders Funds Annual | 115.07 | 69.53 | 56.78 |
| Total Assets Annual | 140.66 | 94.39 | 92.42 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 13.98 |
| Total Current Assets Annual | 33.88 |
| Non Current Assets Annual | 106.78 |
| Total Shareholders Funds Annual | 115.07 |
| Total Assets Annual | 140.66 |
EPS (INR)
Expected
3.25
Reported
3.25
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
